![](https://www.ebrd.com/image/1395324809557.jpg)
EBRD exits Ibnsina Pharma in Egypt
EBRD sells its remaining 8.8 per cent stake in Ibnsina Pharma through the Egyptian Exchange Company’s revenue and EBITDA have increased more than tenfold since the Bank invested in it Ibnsina Pharma is the top pharma distributor in Egypt, with a 30 per …